Novel diagnostic platforms are bringing possibilities for improved patient care and reduced healthcare costs. We spoke with Dr Edgar Goluch, the CEO and founder of QSM Diagnostics,

In the recently published paper in Talenta from Dr Mark Platt and the team at Loughborough University, they demonstrate a novel approach for aptamer biosensors to detect…

Detecting and quantifying small molecule analytes can be difficult. Our specially designed displacement approach allows us to select aptamers that can directly be used in various biosensor platforms for…

Aptamer Technology Platform We develop aptamers (short, synthetic DNA- or RNA-based molecules) under strict laboratory conditions using our automated high-throughput selection platform. Aptamers have flexible, sequence-specific structures that…

AptaBlot – increasing the utility of Western Blotting Western Blotting is a powerful technique used to detect and identify proteins. Antibodies have traditionally been used as the detection…

Flow Cytometry Flow Cytometry is a technique used to identify biomarkers on cell surfaces and intracellular molecules. Most flow cytometers use fluorescently labelled antibodies to differentiate between cells…

There is a growing need for easy to use, point of care tests. A technology where aptamers can be used to achieve this is in lateral flow assays. A…

Proteins can undergo post-translational modification (PTM) of their amino acids which can lead to a change in their activity and increase their functional repertoire. The most common of these…

Flow cytometry has gained popularity and demand in the field of biology because of its accuracy and potential for high throughput analysis. The use of multiple lasers, affinity ligands…

The world is currently gripped by the novel COVID-19 crisis caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is a highly pathogenic viral respiratory illness. It is…